Christi Waarich | Director of Investor Relations |
Bryan Stuart | President and Chief Executive Officer |
Judy Dunn | President of R&D |
Esther Rajavelu | Chief Financial Officer |
Chris Morabito | Chief Medical Officer |
Dae Gon Ha | Stifel |
Joseph Schwartz | SVB Securities |
Matthew Harrison | Morgan Stanley |
Judah Frommer | Credit Suisse |
Ted Tenthoff | Piper Sandler |
00:02 Good morning and welcome to Fulcrum Therapeutics’ Fourth Quarter and Full-Year 2021 Conference Call. Currently all participants are in listen-only mode. There will be a question-and-answer session at the end of this call. 00:15 I would now like to turn the call over to Christi Waarich, Director of Investor Relations at Fulcrum. Please proceed.